{"nct_id":"NCT02081378","title":"A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2014-04-24","start_date_type":"ACTUAL","primary_completion_date":"2021-06-03","primary_completion_date_type":"ACTUAL","completion_date":"2023-03-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}